Financial statements Bio-Tech
Balance sheet of Bio-Tech
Company age:
Age:
11 y. 6 m. 17 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BIO-TECH
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 4 590,33 | 6 079,33 | 6 079,33 | 4 322,18 | 4 597,18 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 4 590,33 | 6 079,33 | 6 079,33 | 4 322,18 | 4 597,18 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 590,33 | 6 079,33 | 6 079,33 | 4 322,18 | 4 597,18 |
| A. Equity | 3 114,33 | 3 004,33 | 3 004,33 | 2 066,18 | 341,18 |
| B. Liabilities and provisions for liabilities | 1 476,00 | 3 075,00 | 3 075,00 | 2 256,00 | 4 256,00 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.